These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16120379)

  • 1. Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy.
    Lewis W
    Mitochondrion; 2004 Jul; 4(2-3):141-52. PubMed ID: 16120379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brief overview of mechanisms of mitochondrial toxicity from NRTIs.
    Kohler JJ; Lewis W
    Environ Mol Mutagen; 2007; 48(3-4):166-72. PubMed ID: 16758472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective.
    Lewis W; Day BJ; Copeland WC
    Nat Rev Drug Discov; 2003 Oct; 2(10):812-22. PubMed ID: 14526384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell culture models for the investigation of NRTI-induced mitochondrial toxicity. Relevance for the prediction of clinical toxicity.
    Höschele D
    Toxicol In Vitro; 2006 Aug; 20(5):535-46. PubMed ID: 16406476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy.
    Lewis W
    Prog Cardiovasc Dis; 2003; 45(4):305-18. PubMed ID: 12638094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies.
    McComsey GA; Walker UA
    Mitochondrion; 2004 Jul; 4(2-3):111-8. PubMed ID: 16120376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of antiretroviral therapy-induced mitochondrial dysfunction.
    Côté HC
    Curr Opin HIV AIDS; 2007 Jul; 2(4):253-60. PubMed ID: 19372896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
    Lewis W
    Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors.
    Olivero OA
    Environ Mol Mutagen; 2007; 48(3-4):215-23. PubMed ID: 16395695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial studies in HAART-related lipodystrophy: from experimental hypothesis to clinical findings.
    Miró O; López S; Cardellach F; Casademont J
    Antivir Ther; 2005; 10 Suppl 2():M73-81. PubMed ID: 16152708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals.
    Gerschenson M; Shiramizu B; LiButti DE; Shikuma CM
    Antivir Ther; 2005; 10 Suppl 2():M83-9. PubMed ID: 16152709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions.
    Lewis W
    Antiviral Res; 2003 May; 58(3):189-97. PubMed ID: 12767466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA base excision repair and mitochondrial DNA mutation in human hepatic HuH-7 cells exposed to stavudine.
    Wu Y; Li N; Zhang T; Wu H; Huang C; Chen D
    Mutat Res; 2009 May; 664(1-2):28-38. PubMed ID: 19428378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
    Côté HC
    Antivir Ther; 2005; 10 Suppl 2():M3-11. PubMed ID: 16152702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV and mitochondrial toxicity in children.
    Foster C; Lyall H
    J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels.
    De Felipe B; Blanco A; Soriano-Sarabia N; Muñoz-Fernández MA; Genebat M; Vallejo A; Leal M
    Infection; 2008 Jun; 36(3):266-70. PubMed ID: 18463785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid analysis of mitochondrial DNA depletion by fluorescence in situ hybridization and immunocytochemistry: potential strategies for HIV therapeutic monitoring.
    Janes MS; Hanson BJ; Hill DM; Buller GM; Agnew JY; Sherwood SW; Cox WG; Yamagata K; Capaldi RA
    J Histochem Cytochem; 2004 Aug; 52(8):1011-8. PubMed ID: 15258176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity.
    Walker UA; Venhoff N
    Antivir Ther; 2005; 10 Suppl 2():M117-23. PubMed ID: 16152713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
    Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
    Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.